[Drug therapy of arrhythmia--its therapeutic and adverse effects].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology; D001775:Blood Circulation / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects; D009202:Cardiomyopathies / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000627:therapeutic use; D004562:Electrocardiography; D006321:Heart / Q000187:drug effects; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D008875:Middle Aged; D008517:Phytotherapy; D010946:Plants, Medicinal; D011342:Procainamide / Q000009:adverse effects; D011802:Quinidine / Q000009:adverse effects / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity; D011926:Rauwolfia / Q000627:therapeutic use; D013565:Sympatholytics / Q000009:adverse effects / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D013565:Sympatholytics; D011802:Quinidine; D011342:Procainamide